Analytikere: Nyt studie med Alzheimers-middel presser Lundbeck-aktien
Relaterede artikler
Tredje fase 3-forsøg på vej for Lundbeck-håb
For abonnenter
Lundbeck starter to fase 3-studier med lægemiddelhåb
For abonnenter
En del af Watch Medier
For abonnenter
For abonnenter
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
NyhedsbrevsvilkårFor abonnenter
For abonnenter
For abonnenter
Head of Quality Assurance
Produktionskemiker
Principal Bioinformatic Scientist, Antibody Technology
Global Head of Rewards
Principal Quality Assurance Professional – Combination Products
Quality Engineer for Production
Investor Relations Manager
Environmental Monitoring Professional
QA/RA Specialist, Patient Handling Division
Material Scientist and Coordinator
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
Senior Laboratory Technician (Laborant) – Biophysical Protein Characterization
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
Principal Research Scientist within Biophysical characterisation and pre-formulation
Head of OTC Product Development
Business Development Manager
ESG Officer
Governmental Public Affairs & Communications Head
QP delegate Biologics, CMC
QA Manager GMP
Skilled Process Specialist for managing logistic and production processes in SAP
Senior Legal Counsel